Tilak Mandadi
At a glance: Tilak Mandadi is Evp, Chief Exp & Tech Officer at CVS Health (CVS). Their latest SEC Form 4, filed May 11, 2026, reported a sale of $6.2M. On file: 0 purchase lines ($0) and 1 sale line ($6.2M).
Disclosed holdings: about $811K of CVS stock: 10,133 shares reported on their latest Form 4 (filed May 11, 2026), valued at the Nov 19, 2026 close of $80.02. This counts only CVS shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Evp, Chief Exp & Tech Officer at CVS HEALTH Corp (CVS)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| May 11SEC | CVSCVS HEALTH Corp | Sell | 69,55110,133 held (−87%) | $89.58 | $6.2M | -10.7% |
- Sell
Evp, Chief Exp & Tech Officer Tilak Mandadi sold $6.2M of CVS at $89.58 — cuts the stake by 87%.
Follow Tilak Mandadi
Get one email when Tilak Mandadi files a new purchase or sale. Free.
At most one email a day about Tilak Mandadi, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.